ARMP insider trading
NYSE American HealthcareArmata Pharmaceuticals, Inc.: insider trade history from SEC Form 4 filings.
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Company website: www.armatapharma.com
ARMP insider activity at a glance
FilingIQ tracks 16 insider transactions for ARMP in filings since Mar 31, 2020. The most recent transaction is dated Jul 10, 2026.
Across the full history, 6 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ARMP insider trades is 55.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ARMP Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ARMP?
- FilingIQ tracks 16 Form 4 insider transactions for ARMP (Armata Pharmaceuticals, Inc.), covering filings from Mar 31, 2020 onwards. 1 of those are dated within the last 90 days.
- Are ARMP insiders net buyers or net sellers?
- Across the full Form 4 history for ARMP, 6 transactions (38%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ARMP insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is ARMP in?
- Armata Pharmaceuticals, Inc. (ARMP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $301.81M.
Methodology & sources
Every ARMP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.